Public Company News

Abbisko Therapeutics Receives CDE Approval of Breakthrough Therapy Designation for Irpagratinib (ABSK011) in the Treatment of HCC

SHANGHAI, May 26, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) announced that its self-developed, highly selective small molecule FGFR4 inhibitor, irpagratinib (ABSK011), has received approval of Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of the Chi...

2025-05-26 12:15 2831

Hong Leong Bank Enhances HLB Private Bank and Regional Wealth Management with Strategic Alliance with Lombard Odier

Integrating A Strategic Alliance with Swiss Private Bank Lombard Odier, Key Talent Acquisitions, Development Programs,and AI Tools, the Bank is Poised to Accelerateits Regional Wealth Management Proposition KUALA LUMPUR, Malaysia, May 26, 2025 /PRNewswire/ -- Hong Leong Bank ("HLB" or "the Bank...

2025-05-26 12:06 2769

Trina Storage Earns Sixth Consecutive BloombergNEF Tier 1 Ranking in Q2 2025

Demonstrating Global Leadership with Integrated Capabilities and Bankable Solutions SHANGHAI, May 26, 2025 /PRNewswire/ -- Trina Storage has been named as the Global Tier 1 Energy Storage Manufacturer in BloombergNEF (BNEF)'s Energy Storage Tier 1 List for Q2 2025. This marks the sixth consecut...

2025-05-26 11:00 3551

Soundcore Liberty 5: Revolutionizing Voice-Canceling with Adaptive ANC 3.0 and Dolby Audio

Top 3 Global Wireless Audio Brand [1]  Unveils Next-Gen Travel-Ready Earbuds HO CHI MINH CITY, Vietnam, May 26, 2025 /PRNewswire/ -- Soundcore, the premium audio brand under Anker Innovations and ranked third globally in wireless headphone shipments, today launched its groundbreaking product, th...

2025-05-26 11:00 2432

Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)

SAN FRANCISCO and SUZHOU, China, May 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...

2025-05-26 08:00 3477

EDAN Highlights Commitment to Global Health at GHF 2025 Satellite Symposium, a Side Event of the World Health Assembly

GENEVA, May 25, 2025 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a leading global medical device company, participated in the Geneva Health Forum (GHF) 2025 Satellite Symposium, held as a side event of the World Health Assembly (WHA). Titled "China's Medical Techno...

2025-05-25 21:41 3010

Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025

SHENZHEN, China, May 25, 2025 /PRNewswire/ -- Mindray  (SZSE: 300760), a leading global developer of healthcare technologies, launched itsBeneVision V Series patient monitoring solution at Euroanaesthesia 2025 in Lisbon. Powered by a robust new hardware platform, this ad...

2025-05-25 19:00 3247

Soundcore Liberty 5: Revolutionizing Voice-Canceling with Adaptive ANC 3.0 and Dolby Audio

Top 3 Global Wireless Audio Brand[1] Unveils Next-Gen Travel-Ready Earbuds SINGAPORE, May 25, 2025 /PRNewswire/ -- Soundcore, the premium audio brand under Anker Innovations and ranked third globally in wireless headphone shipments, today launched its groundbreaking product, the Liberty 5 in Si...

2025-05-25 14:00 3736

COMPUTEX 2025: MiTAC Powers Sustainable AI Data Centers with New Server & Cooling Tech

TAIPEI, May 24, 2025 /PRNewswire/ -- At COMPUTEX 2025, MiTAC Computing Technology Corp., a subsidiary of MiTAC Holdings Corp. (TWSE: 3706), unveiled its bold new vision: from hardware provider to full-solution AI and data center innovator. With future-ready solutions covering AI training and infe...

2025-05-24 14:52 5705

Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths

* YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] * Celltrion previously received interchangeability (IC) designation for YUFLYMA® (adalimumab-aaty) in prefilled syringes (20mg & 80mg); Expanded interchangeabilit...

2025-05-24 01:47 4327

/DISREGARD RELEASE: Celltrion/

We are advised by Celltrion that journalists and other readers should disregard the news release, Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths, issued21-May-2025 over PR Newswire. ...

2025-05-24 00:01 4239

TWSC Debuts at COMPUTEX 2025: Empowering AI with Full-Stack Storage Solutions

TAIPEI, May 23, 2025 /PRNewswire/ -- From May 20 to 23, 2025, TWSC  made its debut at COMPUTEX 2025, one of the world's leading technology exhibitions, under the theme "Transcending Intelligence, Ascending Full-Stack Solutions." The company showcased a full range of stora...

2025-05-23 22:08 5627

Mabwell Announces Clinical Data of Multiple ADCs to be presented at 2025 ASCO Annual Meeting

SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, including phase Ib/II clini...

2025-05-23 22:00 4310

Tongcheng Travel 2025Q1 Secures Foothold in the Mass Travel Market Revenue Grows 13.2% Yoy to RMB4.4 Billion

Rising Travel Spending Boosts Core OTA Business Growth AI Empowers High-Quality Development Across the Travel Industry Chain HONG KONG, May 23, 2025 /PRNewswire/ -- Tongcheng Travel Holdings Limited  ("Tongcheng Travel" or the "Company", together with its subsidiaries the "Group", stock code: 0...

2025-05-23 21:13 7078

NYSE Content Advisory: Pre-Market update + Hinge Health, MNTN pop double digits in trading debuts

NEW YORK, May 23, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on May 23rd * Dig...

2025-05-23 20:55 5146

WGC2025 | ENN Leverages "Intelligence + Low Carbon" to Pioneer a New Paradigm for Sustainable Energy Development

LANGFANG, China, May 23, 2025 /PRNewswire/ -- From May 19 to 23, 2025, the 29th World Gas Conference (WGC2025), hosted by the International Gas Union (IGU), convened inBeijing. As the premier global event in the energy sector, WGC2025 attracted leading companies and industry experts from around t...

2025-05-23 20:00 3959

Eason Technology Limited Receives Notification from NYSE Regarding Delayed Form 20-F Filing

HONG KONG, May 23, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason Technology" or the "Company") (NYSE:DXF

2025-05-23 18:30 4941

Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting

CHENGDU, China, May 23, 2025 /PRNewswire/ -- The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting is scheduled to take place in Chicago, Illinois, USA from May 30 to June 3. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK, the "Company") will present results from six cl...

2025-05-23 17:24 4822

Tuniu Announces Receipt of Minimum Bid Price Notice from Nasdaq

NANJING, China, May 23, 2025 /PRNewswire/ -- Tuniu Corporation (Nasdaq: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced that it has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market L...

2025-05-23 17:00 4354

MINISO Group Announces March Quarter 2025 Unaudited Financial Results

Revenue grew 18.9 % year over year Significant sequential improvement of same-store sales(1) in MINISO mainland China for March Quarter Gross margin reached 44.2%, up 0.8 ppt year over year Adjusted EBITDA increased 7.5% year over year to RMB1,037.3 million Shareholder returns reached around RM...

2025-05-23 16:33 7545

Week's Top Stories